Wuhan (Novel) Corona Virus -looming pandemy of deadly pneumonia? - Pandemy ongoing!

(January 22, 2021) Secretive Tech Company Palantir Gains a New Board Member
The company, which went public via a direct listing in September 2020, announced that Lauren Friedman Stat has joined
its Board of Directors and will serve on its Audit Committee as of January 18, 2021.
Stat has spent the last 15 years as an Accenture employee,
where she most recently served as a Managing Director in the company’s Health practice.
Her deep health background could be of great use to Palantir as it continues to grow its presence in health-related industries.
In October 2020, the company announced it would create a tool that can track the manufacture of COVID-19 vaccines
and help determine where they should be sent. Additionally, Palantir secured a three year, $44 million deal
with the U.S. Food and Drug Administration in December 2020, to use its tech to power drug reviews and inspections.
theorg.com/insights/secretive-tech-company-palantir-gains-a-new-board-member

(January 22, 2021) Amazon to open pop-up COVID-19 vaccine clinic in Seattle headquarters
Amazon Inc said on Thursday it will open a pop-up clinic in its Seattle headquarters on Jan. 24 with an aim to vaccinate 2,000 eligible members
of the public against COVID-19 on the first day. Amazon Senior Vice President of Global Corporate Affairs Jay Carney, who announced the plan
in a news conference with Washington Governor Jay Inslee, said a company executive will be working with Washington State’s Vaccine Command Center.
The clinic will be hosted in partnership with Virginia Mason Franciscan Health. The move came a day after Reuters reported that Amazon
had offered to help with the United States’ efforts involving the COVID-19 vaccine, citing a letter addressed to President Joe Biden.
asiainsurancepost.com/ecoinvestdemography/amazon-open-pop-covid-19-vaccine-clinic-seattle-headquarters

(January 22, 2021) The Old Lady Who Swallowed a Fly - USA’s economic collapse and the dollar’s demise
Bringing together the US emergency bank lending crisis and the now massive Covid response,
I’ve concluded that one of the main reasons it is happening, apart from the corporate looting,
is because of a historic event, the USA’s economic collapse and the dollar’s demise,
which started just weeks before this Covid operation kicked off,
and has been put on hold by a world wide manufactured economic ‘freeze’.

A few months before Covid appeared, the Fed were busy pouring literally trillions of dollars into the US banks,
to prevent inter-lending bank-runs which were starting to develop.
These were the same tectonic fissures that developed prior to the 2008 crisis,
where the banks became so distrustful of each other’s solvency, that they massively increased interest rates
to each other to factor in the risk. If unsuppressed the lending rates would continue to rise,
laying a path to bank failures and a contagion which would eventually derail the economy and undermine the dollar itself.
off-guardian.org/2021/01/22/the-old-lady-who-swallowed-a-fly/

Ivermectin:

Governments need to be held accountable for the tens of thousands of needless deaths, I have seen many video's from professionals calling Ivermectin a "Wonder drug" and a "Game changer" in the fight against Covid, only to see them censored from the net.

Here is another credible video from another professional...

(January 22, 2021) Pfizer, BioNTech Enter Vax Pact with COVAX
Pfizer and BioNTech entered an advance purchase agreement with COVAX for up to 40 million doses
of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021.
Financial terms were not disclosed.
COVAX is a global initiative coordinated by the Global Alliance for Vaccines and Immunization (GAVI),
the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO),
to ensure equitable access to COVID-19 vaccines for all countries.
The first doses are expected to be delivered in the first quarter of 2021,
subject to the negotiation and execution of supply agreements under the COVAX Facility structure.
contractpharma.com/content-microsite/covid-19/2021-01-22/pfizer-biontech-enter-vax-pact-with-covax?widget=listSection

(January 25, 2021) Novavax inks agreement with Government of Canada to supply up to 76 million doses of recombinant protein-based Covid-19 vaccine, NVX-CoV2373
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases,
announced that it has finalized an agreement with the Government of Canada to supply up to 76 million doses of NVX-CoV2373,
the company’s recombinant protein-based Covid-19 vaccine. Canada has committed to purchase 52 million doses
of the vaccine with the option for up to an additional 24 million doses.
NVX-CoV2373 is currently in phase 3 clinical development for the prevention of Covid-19.
The company expects to supply NVX-CoV2373 to Canada beginning as early as the second quarter of 2021,
following authorization by Canada’s regulatory agency.
pharmabiz.com/NewsDetails.aspx?aid=135048&sid=2

(January 25, 2021) Humanigen, Emergent Enter Covid-19 Partnership
Emergent BioSolutions and Humanigen have entered into a contract development and manufacturing (CDMO)
services agreement to accelerate the drug product manufacturing of lenzilumab,
an anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody
designed to prevent and treat an immune hyper-response called “cytokine storm.”
Emergent will provide access to manufacturing capacity reserved for and provided by the U.S. government
under Humanigen’s Cooperative Research and Development Agreement (CRADA) with the Department of Defense’s (DoD)
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)
in collaboration with the Biomedical Advanced Research and Development Authority (BARDA),
part of the Office of the Assistant Secretary for Preparedness and Response (ASPR)
at the U.S. Department of Health and Human Services. Lenzilumab is currently in a Phase 3 clinical trial
evaluating patients hospitalized with COVID-19. Humanigen intends to file for emergency use authorization (EUA) in the first quarter of 2021.
contractpharma.com/content-microsite/covid-19/2021-01-25/humanigen-emergent-enter-covid-19-partnership

(January 25, 2021) Merck's COVID-19 Vaccine Candidates Discountinued
New Jersey-based Merck (MSD) announced that the company is discontinuing
the development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591.
This decision follows Merck’s review of findings from Phase 1
clinical studies for the vaccines, stated a Merck press statement.
Merck and its collaborators plan to submit the results of the Phase 1 studies for V590 and V591 for publication in a peer-reviewed journal.
precisionvaccinations.com/vaccine-breaking-news

The Chinese biological laboratory in Wuhan is owned by Glaxosmithkline who (by coincidence)owns Pfizer!the one who produces the vaccine for the virus that (by coincidence) started in the biological laboratory in Wuhan which(by coincidence) was funded by Dr Fauci who is (by coincidence)promoting the vaccine.

This lab in Wuhan?

ge.com/news/reports/pfizer-will-use-ges-modular-factory-to-make-next-generation-drugs-in-china?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%253A%20ideaslaboratory%20%2528Ideas%20Laboratory%2529

(January 25, 2021) The USA VAERS pharmacovigilance body has updated the data on adverse events after administration of the Covid vaccine
As of January 15, 2021:
- 180 deaths after the first vaccination
- 44 people died on the day of vaccination
- A perfectly healthy 56-year-old man died just one hour after the second vaccination
medalerts.org/vaersdb/findfield.php?EVENTS=on&PAGENO=1&PERPAGE=10&ESORT=NONE&REVERSESORT=&VAX=(COVID19)&DIED=Yes

Abacus wrote:This lab in Wuhan?

One big circle of faucky with the Jesuit poster boy in the middle.

All of the names on the patent were in the Atlanta area.
University of North Carolina was in on it too.

(January 26, 2021) Norway May Refine Vaccine Strategy After Elderly Deaths, PM Says
The Prime Minister of Norway, Erna Solberg, says her country may fine-tune the vaccination of its oldest,
sickest citizens as it tries to make sense of a recent spate of deaths.
Having weathered the pandemic better than most, Norway suddenly made international headlines
this month after revealing that more than 30 people -- all over 70 and all already sick -- died
not long after being vaccinated against Covid-19.
“We don’t believe there’s any problem with the safety of the vaccines,”
Solberg said in an interview with Bloomberg Live that aired on Tuesday.
“But we will maybe not give them to the most vulnerable of the elderly, because that might speed up a process
where they were what we would say at the end of life phase anyway,” so, “that probably is not what we will continue to do.”
bloomberg.com/news/articles/2021-01-26/norway-may-refine-vaccine-strategy-after-elderly-deaths-pm-says

What do you make of Gibraltar as at a few days ago it looks like a high number of people have died after being vaccinated there?

Indeed, thanks for info @khnum.

(January 26, 2021) Gibraltar tops world stats in vaccine rollout, but also deaths per capita
Gibraltar now ranks second in the world of countries with the largest percentage of individual doses of the Covid vaccine administered.
It is also the top country in the world with the most covid tests done per million of the population.
However it is also ranked top in the world of deaths per million people,
and second in the world of countries with the most cases per million people.
gbc.gi/news/gib%C2%A0tops-world-stats%C2%A0-vaccine-rollout-also-deaths-capita

(January 26, 2021) Abbott Panbio rapid antigen test wins CE mark for asymptomatic COVID-19 screening
Abbott (NYSE:ABT) announced today that it received CE Mark for two new uses of its Panbio COVID-19 Ag rapid diagnostic.
Panbio COVID-19 Ag has received an updated label with clinical data on asymptomatic individuals to enable mass testing
of people who do not currently present symptoms of the disease, according to a news release.
The other update allows for self-collection of nasal specimens under the supervision of a healthcare worker,
offering improved patient comfort and reduced risk of accidental exposure to the virus
for healthcare workers as they can maintain their distance during testing.
Abbott Park, Ill.-based Abbott has shipped 200 million Panbio rapid antigen tests across 120 countries
in Europe, the Americas, Asia and Africa since August 2020. The company has coordinated with the Global Fund,
the World Health Organization and the Bill & Melinda Gates Foundation to make the tests available to low- and middle-income countries.
Panbio is not avialable in the U.S. as Abbott manufactures and sells the BinaxNow COVID-19 Ag Card, which has FDA emergency use authorization (EUA).
massdevice.com/abbott-panbio-rapid-antigen-test-wins-ce-mark-for-asymptomatic-screening/

(January 23, 2021) OraSure’s Oragene Dx saliva collection kit included in industry’s first US FDA authorization for whole exome sequencing platform
OraSure Technologies, a leader in point-of-care diagnostic tests, specimen collection devices, announced that its Oragene Dx (OGD-610) saliva collection device
was included as a component in the De Novo authorization granted by the US Food & Drug Administration (FDA)
to Helix for their Helix Laboratory Platform, a whole exome sequencing platform.
This is the first exome sequencing-based platform authorized by the FDA.
Oragene Dx is a product of OraSure’s DNA Genotek subsidiary.
In 2020, Oragene Dx received US Food and Drug Administration (FDA) general use 510(k)
clearance and remains the first and only device with general clearance for collection and stabilization of DNA from saliva
for use in genetic testing, including prescription or over-the-counter (direct-to-consumer) use.
Saliva samples collected using Oragene Dx are stabilized for use in downstream diagnostic testing
applications and can be transported and/or stored long-term at ambient temperatures.
pharmabiz.com/NewsDetails.aspx?aid=134987&sid=2

(January 26, 2021) Chronomics selects OraSure's OMNIgene ORAL salive collection kit
OraSure Technologies announced that Chronomics Limited has selected the OMNIgeneORAL saliva collection device
as a component of its SARS CoV-2 PCR test. Chronomics Limited will supply its test for the United Kingdom's
"Test to Release for International Travel" program. The OMNIgeneORAL device is a product of OraSure's DNA Genotek subsidiary.
The "Test to Release for International Travel" program enables travelers to England to purchase a COVID-19 test privately from providers including Chronomics.
Travelers who receive a negative test result can reduce their self-isolation period.
The project is part of the UK's plan to use Covid-19 testing to reduce the spread of the virus.
thefly.com/landingPageNews.php?id=3233595&headline=OSUR-Chronomics-selects-OraSures-OMNIgene-ORAL-salive-collection-kit

This is a great interview, pretty much covers everything about the "pandemic"

Download because this will not be up for long.

(January 28, 2021) India has capability to strengthen global supply chain: PM Modi at World Economic Forum
Prime Minister Narendra Modi on Thursday said that India has braved all difficulties
in fight against coronavirus pandemic and has the capability to strengthen global supply chains.
Addressing the World Economic Forum's Davos Dialogue via video conferencing,
Modi said that India launched 'Aatmanirbhar Bharat Abhiyan' with the resolve of increasing the capacity of our economy.
timesofindia.indiatimes.com/business/india-business/pm-modi-addresses-world-economic-forums-davos-dialogue-key-points/articleshow/80506847.cms

(January 28, 2021) Salesforce announces Vaccine Cloud to accelerate global vaccine management
Salesforce, the global leader in CRM, announced Vaccine Cloud, technology to help government agencies, healthcare organizations, businesses,
non-profits and educational institutions more rapidly, safely and efficiently deploy and manage their vaccine programmes.
Currently, international, federal, state and local agencies, healthcare providers and non-profits worldwide are using Salesforce technology specifically for vaccine administration,
including Northwell Health, Illinois' Lake County, University of Massachusetts Amherst, Gavi, the Vaccine Alliance and more.
Government agencies and public health agencies can use Vaccine Cloud to monitor their vaccination progress with data and insights,
which helps enable them to maximize their programme effectiveness. This includes securing enough doses, monitoring patient outcomes,
and making data-driven decisions based on community health needs and risk factors.
Salesforce partners extend the power of Vaccine Cloud to scale vaccine programmes for government, healthcare organizations and non-profits worldwide.
These include Accenture, Deloitte, IBM and KPMG, in addition to partners Coastal Cloud, Infosys, MTX, PolSource, Sense Corp, Silverline,
Skedulo, Slalom and Traction on Demand are already leveraging Vaccine Cloud solutions to help organizations accelerate their vaccine management programmes.
pharmabiz.com/NewsDetails.aspx?aid=135114&sid=2

(January 27, 2021) COMIRNATY becomes first COVID-19 vaccine to receive EUA in Hong Kong
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. have announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region
of the PRC, the COVID-19 vaccine COMIRNATY (also known as BNT162b2) based on BioNTech's proprietary mRNA technology
has received emergency use authorisation (EUA) in Hong Kong. The vaccine will be produced in BioNTech's manufacturing facilities in Germany,
and supplied to Hong Kong for administration under the Hong Kong SAR Government's COVID-19 Vaccination Program.
biospectrumasia.com/news/37/17495/comirnaty-becomes-first-covid-19-vaccine-to-receive-eua-in-hong-kong.html

(January 28, 2021) Biden administration promises $20bn for US vaccination programme and buys additional vaccine doses
The Biden administration is planning to ask Congress for approval of $415bn in emergency spending for Covid-19 vaccination, testing, contact tracing, genomic sequencing,
and other efforts to fight Covid-19 as part of a $1.9 trillion stimulus programme. Of these funds, $20bn will be allocated for a national vaccination programme,
$30bn for purchasing supplies and protective gear, and $50bn for a scaled-up diagnostic testing programme.
On 26 January, the White House further announced plans to buy 200 million additional vaccine doses from Pfizer / BioNTech
and Moderna and to increase the number of vaccine doses distributed weekly to states from 8.6 million to 10 million.
pharmaceutical-technology.com/comment/us-vaccination-programme/

(January 27, 2021) Exclusive: Tony Blair calls on Boris Johnson to lead drive for global vaccine passport
Tony Blair has called on the Government to establish a single global vaccine passport scheme through the G7,
or risk others dictating the rules. In a detailed report published by the Tony Blair Institute (TBI),
he said current border restrictions were “disjointed” and urged the UK to “place the creation of a global Covid-19 travel pass
as a key item on the G7 agenda” - a body which Britain currently leads.
The report added that the much tougher international travel restrictions
announced on Wednesday by the Prime Minister would be much more difficult to eventually unwind without a vaccine passport.
Mr Blair said the passport should be digital and capable of tracking and verifying
an individual’s coronavirus “status” wherever they travel in the world.
Included would be details of any vaccination they had,
together with the results of Covid-19 test results.
telegraph.co.uk/global-health/science-and-disease/exclusive-tony-blair-calls-boris-johnson-lead-drive-global-vaccine/